Shop / Cancer screening
Cancer screening
Cancer is the leading cause of death in adult dogs. Blood can now see it early.
Systems touched: Immune, integumentary and endocrine systems most directly.
What this category actually does
Liquid biopsy and nucleosome assays detect tumour-derived material in a single blood draw, which makes annual screening possible for dogs at breed or age risk long before a mass is palpable. Where cancer is already present, tumour sequencing matches targeted therapies to the specific mutations driving it rather than working through generic protocols. All of it is ordered through your veterinarian.
Key benefits
01
Detection before symptoms
Screening at the annual visit finds disease at a stage where intervention still changes the outcome.
02
Low-friction sampling
A blood draw during routine bloodwork, no sedation, no imaging suite.
03
Targeted rather than generic therapy
Tumour genomics narrows drug choice using outcome data from thousands of treated dogs.
04
Risk-weighted intervals
High-risk breeds and dogs over seven benefit most, and the schedule should say so.
3 products in cancer screening
OncoK9
PetDx
Liquid-biopsy blood test for multi-cancer detection.
Validated in the CANDiD study across more than a thousand dogs, cancer detection from a single blood draw.
- Availability
- Vet-ordered
- Cost
- Price varies by clinic
Nu.Q Vet Cancer Test
Volition Veterinary
Blood test measuring circulating nucleosomes.
A low-cost screen that can be run at annual visits rather than only after symptoms appear.
- Availability
- Available through clinics
- Cost
- Price varies by clinic
FidoCure
One Health Company
Precision oncology programme for dogs with cancer.
Sequences the tumour, then matches targeted therapies using one of the largest canine cancer outcome datasets in existence.
- Availability
- Prescription, via your vet
- Cost
- Price varies
Get the screening calendar right
Your Council sets screening frequency from breed, age and genomic risk, not a generic checklist.